5-[3-(6-amino-2-methylpyrimidin-4-yl)oxyphenyl]-N-(3-methylphenyl)-1,3,4-oxadiazol-2-amine;5-[3-[(2-amino-4-pyridinyl)oxy]phenyl]-N-(3-methylphenyl)-1,3,4-oxadiazol-2-amine;5-[3-(7-methoxyquinolin-4-yl)oxyphenyl]-N-(3-methylphenyl)-1H-1,2,4-triazol-3-amine;4-[3-[5-(3-methylanilino)-1,3,4-oxadiazol-2-yl]phenoxy]pyridine-3-sulfonamide;6-[3-[3-(3-methylanilino)-1H-1,2,4-triazol-5-yl]phenoxy]pyrimidine-2,4-diamine;N-(3-methylphenyl)-5-(3-pyridin-4-yloxyphenyl)-1,3,4-oxadiazol-2-amine;N-(3-methylphenyl)-5-[3-(7H-pyrrolo[2,3-d]pyrimidin-4-yloxy)phenyl]-1H-1,2,4-triazol-3-amine;N-(3-methylphenyl)-5-(3-quinolin-4-yloxyphenyl)-1H-1,2,4-triazol-3-amine

C169H143N45O15S — CID 159560328

About 5-[3-(6-amino-2-methylpyrimidin-4-yl)oxyphenyl]-N-(3-methylphenyl)-1,3,4-oxadiazol-2-amine;5-[3-[(2-amino-4-pyridinyl)oxy]phenyl]-N-(3-methylphenyl)-1,3,4-oxadiazol-2-amine;5-[3-(7-methoxyquinolin-4-yl)oxyphenyl]-N-(3-methylphenyl)-1H-1,2,4-triazol-3-amine;4-[3-[5-(3-methylanilino)-1,3,4-oxadiazol-2-yl]phenoxy]pyridine-3-sulfonamide;6-[3-[3-(3-methylanilino)-1H-1,2,4-triazol-5-yl]phenoxy]pyrimidine-2,4-diamine;N-(3-methylphenyl)-5-(3-pyridin-4-yloxyphenyl)-1,3,4-oxadiazol-2-amine;N-(3-methylphenyl)-5-[3-(7H-pyrrolo[2,3-d]pyrimidin-4-yloxy)phenyl]-1H-1,2,4-triazol-3-amine;N-(3-methylphenyl)-5-(3-quinolin-4-yloxyphenyl)-1H-1,2,4-triazol-3-amine

5-[3-(6-amino-2-methylpyrimidin-4-yl)oxyphenyl]-N-(3-methylphenyl)-1,3,4-oxadiazol-2-amine;5-[3-[(2-amino-4-pyridinyl)oxy]phenyl]-N-(3-methylphenyl)-1,3,4-oxadiazol-2-amine;5-[3-(7-methoxyquinolin-4-yl)oxyphenyl]-N-(3-methylphenyl)-1H-1,2,4-triazol-3-amine;4-[3-[5-(3-methylanilino)-1,3,4-oxadiazol-2-yl]phenoxy]pyridine-3-sulfonamide;6-[3-[3-(3-methylanilino)-1H-1,2,4-triazol-5-yl]phenoxy]pyrimidine-2,4-diamine;N-(3-methylphenyl)-5-(3-pyridin-4-yloxyphenyl)-1,3,4-oxadiazol-2-amine;N-(3-methylphenyl)-5-[3-(7H-pyrrolo[2,3-d]pyrimidin-4-yloxy)phenyl]-1H-1,2,4-triazol-3-amine;N-(3-methylphenyl)-5-(3-quinolin-4-yloxyphenyl)-1H-1,2,4-triazol-3-amine (PubChem CID 159560328) has the molecular formula C169H143N45O15S and a molecular weight of 3076.37 g/mol. Its IUPAC name is 5-[3-(6-amino-2-methylpyrimidin-4-yl)oxyphenyl]-N-(3-methylphenyl)-1,3,4-oxadiazol-2-amine;5-[3-[(2-amino-4-pyridinyl)oxy]phenyl]-N-(3-methylphenyl)-1,3,4-oxadiazol-2-amine;5-[3-(7-methoxyquinolin-4-yl)oxyphenyl]-N-(3-methylphenyl)-1H-1,2,4-triazol-3-amine;4-[3-[5-(3-methylanilino)-1,3,4-oxadiazol-2-yl]phenoxy]pyridine-3-sulfonamide;6-[3-[3-(3-methylanilino)-1H-1,2,4-triazol-5-yl]phenoxy]pyrimidine-2,4-diamine;N-(3-methylphenyl)-5-(3-pyridin-4-yloxyphenyl)-1,3,4-oxadiazol-2-amine;N-(3-methylphenyl)-5-[3-(7H-pyrrolo[2,3-d]pyrimidin-4-yloxy)phenyl]-1H-1,2,4-triazol-3-amine;N-(3-methylphenyl)-5-(3-quinolin-4-yloxyphenyl)-1H-1,2,4-triazol-3-amine.

Molecular Properties

• Compound Name: 5-[3-(6-amino-2-methylpyrimidin-4-yl)oxyphenyl]-N-(3-methylphenyl)-1,3,4-oxadiazol-2-amine;5-[3-[(2-amino-4-pyridinyl)oxy]phenyl]-N-(3-methylphenyl)-1,3,4-oxadiazol-2-amine;5-[3-(7-methoxyquinolin-4-yl)oxyphenyl]-N-(3-methylphenyl)-1H-1,2,4-triazol-3-amine;4-[3-[5-(3-methylanilino)-1,3,4-oxadiazol-2-yl]phenoxy]pyridine-3-sulfonamide;6-[3-[3-(3-methylanilino)-1H-1,2,4-triazol-5-yl]phenoxy]pyrimidine-2,4-diamine;N-(3-methylphenyl)-5-(3-pyridin-4-yloxyphenyl)-1,3,4-oxadiazol-2-amine;N-(3-methylphenyl)-5-[3-(7H-pyrrolo[2,3-d]pyrimidin-4-yloxy)phenyl]-1H-1,2,4-triazol-3-amine;N-(3-methylphenyl)-5-(3-quinolin-4-yloxyphenyl)-1H-1,2,4-triazol-3-amine
• PubChem CID: 159560328
• Molecular Formula: C169H143N45O15S
• Molecular Weight: 3076.37 g/mol
• Exact Mass: 3074.15
• IUPAC Name: 5-[3-(6-amino-2-methylpyrimidin-4-yl)oxyphenyl]-N-(3-methylphenyl)-1,3,4-oxadiazol-2-amine;5-[3-[(2-amino-4-pyridinyl)oxy]phenyl]-N-(3-methylphenyl)-1,3,4-oxadiazol-2-amine;5-[3-(7-methoxyquinolin-4-yl)oxyphenyl]-N-(3-methylphenyl)-1H-1,2,4-triazol-3-amine;4-[3-[5-(3-methylanilino)-1,3,4-oxadiazol-2-yl]phenoxy]pyridine-3-sulfonamide;6-[3-[3-(3-methylanilino)-1H-1,2,4-triazol-5-yl]phenoxy]pyrimidine-2,4-diamine;N-(3-methylphenyl)-5-(3-pyridin-4-yloxyphenyl)-1,3,4-oxadiazol-2-amine;N-(3-methylphenyl)-5-[3-(7H-pyrrolo[2,3-d]pyrimidin-4-yloxy)phenyl]-1H-1,2,4-triazol-3-amine;N-(3-methylphenyl)-5-(3-quinolin-4-yloxyphenyl)-1H-1,2,4-triazol-3-amine
• SMILES: COc1ccc2c(Oc3cccc(-c4nc(Nc5cccc(C)c5)n[nH]4)c3)ccnc2c1.Cc1cccc(Nc2n[nH]c(-c3cccc(Oc4cc(N)nc(N)n4)c3)n2)c1.Cc1cccc(Nc2n[nH]c(-c3cccc(Oc4ccnc5ccccc45)c3)n2)c1.Cc1cccc(Nc2n[nH]c(-c3cccc(Oc4ncnc5[nH]ccc45)c3)n2)c1.Cc1cccc(Nc2nnc(-c3cccc(Oc4cc(N)nc(C)n4)c3)o2)c1.Cc1cccc(Nc2nnc(-c3cccc(Oc4ccnc(N)c4)c3)o2)c1.Cc1cccc(Nc2nnc(-c3cccc(Oc4ccncc4)c3)o2)c1.Cc1cccc(Nc2nnc(-c3cccc(Oc4ccncc4S(N)(=O)=O)c3)o2)c1
• InChI: InChI=1S/C25H21N5O2.C24H19N5O.C21H17N7O.C20H18N6O2.C20H17N5O4S.C20H17N5O2.C20H16N4O2.C19H18N8O/c1-16-5-3-7-18(13-16)27-25-28-24(29-30-25)17-6-4-8-20(14-17)32-23-11-12-26-22-15-19(31-2)9-10-21(22)23;1-16-6-4-8-18(14-16)26-24-27-23(28-29-24)17-7-5-9-19(15-17)30-22-12-13-25-21-11-3-2-10-20(21)22;1-13-4-2-6-15(10-13)25-21-26-18(27-28-21)14-5-3-7-16(11-14)29-20-17-8-9-22-19(17)23-12-24-20;1-12-5-3-7-15(9-12)24-20-26-25-19(28-20)14-6-4-8-16(10-14)27-18-11-17(21)22-13(2)23-18;1-13-4-2-6-15(10-13)23-20-25-24-19(29-20)14-5-3-7-16(11-14)28-17-8-9-22-12-18(17)30(21,26)27;1-13-4-2-6-15(10-13)23-20-25-24-19(27-20)14-5-3-7-16(11-14)26-17-8-9-22-18(21)12-17;1-14-4-2-6-16(12-14)22-20-24-23-19(26-20)15-5-3-7-18(13-15)25-17-8-10-21-11-9-17;1-11-4-2-6-13(8-11)22-19-25-17(26-27-19)12-5-3-7-14(9-12)28-16-10-15(20)23-18(21)24-16/h3-15H,1-2H3,(H2,27,28,29,30);2-15H,1H3,(H2,26,27,28,29);2-12H,1H3,(H,22,23,24)(H2,25,26,27,28);3-11H,1-2H3,(H,24,26)(H2,21,22,23);2-12H,1H3,(H,23,25)(H2,21,26,27);2-12H,1H3,(H2,21,22)(H,23,25);2-13H,1H3,(H,22,24);2-10H,1H3,(H4,20,21,23,24)(H2,22,25,26,27)
• InChIKey: MGNINLOBNQFVRF-UHFFFAOYSA-N
• XLogP: 37.01
• TPSA: 823.09 Ų
• H-Bond Donors: 18
• H-Bond Acceptors: 54
• Rotatable Bonds: 42
• Heavy Atoms: 230
• Complexity: —

Lipinski Rule of Five

4 violations

Rule	Value
MW ≤ 500	3076.37
LogP ≤ 5	37.01
H-Bond Donors ≤ 5	18
H-Bond Acceptors ≤ 10	54

Frequently Asked Questions

What is the IUPAC name of 5-[3-(6-amino-2-methylpyrimidin-4-yl)oxyphenyl]-N-(3-methylphenyl)-1,3,4-oxadiazol-2-amine;5-[3-[(2-amino-4-pyridinyl)oxy]phenyl]-N-(3-methylphenyl)-1,3,4-oxadiazol-2-amine;5-[3-(7-methoxyquinolin-4-yl)oxyphenyl]-N-(3-methylphenyl)-1H-1,2,4-triazol-3-amine;4-[3-[5-(3-methylanilino)-1,3,4-oxadiazol-2-yl]phenoxy]pyridine-3-sulfonamide;6-[3-[3-(3-methylanilino)-1H-1,2,4-triazol-5-yl]phenoxy]pyrimidine-2,4-diamine;N-(3-methylphenyl)-5-(3-pyridin-4-yloxyphenyl)-1,3,4-oxadiazol-2-amine;N-(3-methylphenyl)-5-[3-(7H-pyrrolo[2,3-d]pyrimidin-4-yloxy)phenyl]-1H-1,2,4-triazol-3-amine;N-(3-methylphenyl)-5-(3-quinolin-4-yloxyphenyl)-1H-1,2,4-triazol-3-amine?

The IUPAC name of 5-[3-(6-amino-2-methylpyrimidin-4-yl)oxyphenyl]-N-(3-methylphenyl)-1,3,4-oxadiazol-2-amine;5-[3-[(2-amino-4-pyridinyl)oxy]phenyl]-N-(3-methylphenyl)-1,3,4-oxadiazol-2-amine;5-[3-(7-methoxyquinolin-4-yl)oxyphenyl]-N-(3-methylphenyl)-1H-1,2,4-triazol-3-amine;4-[3-[5-(3-methylanilino)-1,3,4-oxadiazol-2-yl]phenoxy]pyridine-3-sulfonamide;6-[3-[3-(3-methylanilino)-1H-1,2,4-triazol-5-yl]phenoxy]pyrimidine-2,4-diamine;N-(3-methylphenyl)-5-(3-pyridin-4-yloxyphenyl)-1,3,4-oxadiazol-2-amine;N-(3-methylphenyl)-5-[3-(7H-pyrrolo[2,3-d]pyrimidin-4-yloxy)phenyl]-1H-1,2,4-triazol-3-amine;N-(3-methylphenyl)-5-(3-quinolin-4-yloxyphenyl)-1H-1,2,4-triazol-3-amine (CID 159560328) is 5-[3-(6-amino-2-methylpyrimidin-4-yl)oxyphenyl]-N-(3-methylphenyl)-1,3,4-oxadiazol-2-amine;5-[3-[(2-amino-4-pyridinyl)oxy]phenyl]-N-(3-methylphenyl)-1,3,4-oxadiazol-2-amine;5-[3-(7-methoxyquinolin-4-yl)oxyphenyl]-N-(3-methylphenyl)-1H-1,2,4-triazol-3-amine;4-[3-[5-(3-methylanilino)-1,3,4-oxadiazol-2-yl]phenoxy]pyridine-3-sulfonamide;6-[3-[3-(3-methylanilino)-1H-1,2,4-triazol-5-yl]phenoxy]pyrimidine-2,4-diamine;N-(3-methylphenyl)-5-(3-pyridin-4-yloxyphenyl)-1,3,4-oxadiazol-2-amine;N-(3-methylphenyl)-5-[3-(7H-pyrrolo[2,3-d]pyrimidin-4-yloxy)phenyl]-1H-1,2,4-triazol-3-amine;N-(3-methylphenyl)-5-(3-quinolin-4-yloxyphenyl)-1H-1,2,4-triazol-3-amine.

What is the SMILES notation for 5-[3-(6-amino-2-methylpyrimidin-4-yl)oxyphenyl]-N-(3-methylphenyl)-1,3,4-oxadiazol-2-amine;5-[3-[(2-amino-4-pyridinyl)oxy]phenyl]-N-(3-methylphenyl)-1,3,4-oxadiazol-2-amine;5-[3-(7-methoxyquinolin-4-yl)oxyphenyl]-N-(3-methylphenyl)-1H-1,2,4-triazol-3-amine;4-[3-[5-(3-methylanilino)-1,3,4-oxadiazol-2-yl]phenoxy]pyridine-3-sulfonamide;6-[3-[3-(3-methylanilino)-1H-1,2,4-triazol-5-yl]phenoxy]pyrimidine-2,4-diamine;N-(3-methylphenyl)-5-(3-pyridin-4-yloxyphenyl)-1,3,4-oxadiazol-2-amine;N-(3-methylphenyl)-5-[3-(7H-pyrrolo[2,3-d]pyrimidin-4-yloxy)phenyl]-1H-1,2,4-triazol-3-amine;N-(3-methylphenyl)-5-(3-quinolin-4-yloxyphenyl)-1H-1,2,4-triazol-3-amine?

The canonical SMILES for 5-[3-(6-amino-2-methylpyrimidin-4-yl)oxyphenyl]-N-(3-methylphenyl)-1,3,4-oxadiazol-2-amine;5-[3-[(2-amino-4-pyridinyl)oxy]phenyl]-N-(3-methylphenyl)-1,3,4-oxadiazol-2-amine;5-[3-(7-methoxyquinolin-4-yl)oxyphenyl]-N-(3-methylphenyl)-1H-1,2,4-triazol-3-amine;4-[3-[5-(3-methylanilino)-1,3,4-oxadiazol-2-yl]phenoxy]pyridine-3-sulfonamide;6-[3-[3-(3-methylanilino)-1H-1,2,4-triazol-5-yl]phenoxy]pyrimidine-2,4-diamine;N-(3-methylphenyl)-5-(3-pyridin-4-yloxyphenyl)-1,3,4-oxadiazol-2-amine;N-(3-methylphenyl)-5-[3-(7H-pyrrolo[2,3-d]pyrimidin-4-yloxy)phenyl]-1H-1,2,4-triazol-3-amine;N-(3-methylphenyl)-5-(3-quinolin-4-yloxyphenyl)-1H-1,2,4-triazol-3-amine is COc1ccc2c(Oc3cccc(-c4nc(Nc5cccc(C)c5)n[nH]4)c3)ccnc2c1.Cc1cccc(Nc2n[nH]c(-c3cccc(Oc4cc(N)nc(N)n4)c3)n2)c1.Cc1cccc(Nc2n[nH]c(-c3cccc(Oc4ccnc5ccccc45)c3)n2)c1.Cc1cccc(Nc2n[nH]c(-c3cccc(Oc4ncnc5[nH]ccc45)c3)n2)c1.Cc1cccc(Nc2nnc(-c3cccc(Oc4cc(N)nc(C)n4)c3)o2)c1.Cc1cccc(Nc2nnc(-c3cccc(Oc4ccnc(N)c4)c3)o2)c1.Cc1cccc(Nc2nnc(-c3cccc(Oc4ccncc4)c3)o2)c1.Cc1cccc(Nc2nnc(-c3cccc(Oc4ccncc4S(N)(=O)=O)c3)o2)c1.

What is the InChIKey of 5-[3-(6-amino-2-methylpyrimidin-4-yl)oxyphenyl]-N-(3-methylphenyl)-1,3,4-oxadiazol-2-amine;5-[3-[(2-amino-4-pyridinyl)oxy]phenyl]-N-(3-methylphenyl)-1,3,4-oxadiazol-2-amine;5-[3-(7-methoxyquinolin-4-yl)oxyphenyl]-N-(3-methylphenyl)-1H-1,2,4-triazol-3-amine;4-[3-[5-(3-methylanilino)-1,3,4-oxadiazol-2-yl]phenoxy]pyridine-3-sulfonamide;6-[3-[3-(3-methylanilino)-1H-1,2,4-triazol-5-yl]phenoxy]pyrimidine-2,4-diamine;N-(3-methylphenyl)-5-(3-pyridin-4-yloxyphenyl)-1,3,4-oxadiazol-2-amine;N-(3-methylphenyl)-5-[3-(7H-pyrrolo[2,3-d]pyrimidin-4-yloxy)phenyl]-1H-1,2,4-triazol-3-amine;N-(3-methylphenyl)-5-(3-quinolin-4-yloxyphenyl)-1H-1,2,4-triazol-3-amine?

The InChIKey is MGNINLOBNQFVRF-UHFFFAOYSA-N. The full InChI is InChI=1S/C25H21N5O2.C24H19N5O.C21H17N7O.C20H18N6O2.C20H17N5O4S.C20H17N5O2.C20H16N4O2.C19H18N8O/c1-16-5-3-7-18(13-16)27-25-28-24(29-30-25)17-6-4-8-20(14-17)32-23-11-12-26-22-15-19(31-2)9-10-21(22)23;1-16-6-4-8-18(14-16)26-24-27-23(28-29-24)17-7-5-9-19(15-17)30-22-12-13-25-21-11-3-2-10-20(21)22;1-13-4-2-6-15(10-13)25-21-26-18(27-28-21)14-5-3-7-16(11-14)29-20-17-8-9-22-19(17)23-12-24-20;1-12-5-3-7-15(9-12)24-20-26-25-19(28-20)14-6-4-8-16(10-14)27-18-11-17(21)22-13(2)23-18;1-13-4-2-6-15(10-13)23-20-25-24-19(29-20)14-5-3-7-16(11-14)28-17-8-9-22-12-18(17)30(21,26)27;1-13-4-2-6-15(10-13)23-20-25-24-19(27-20)14-5-3-7-16(11-14)26-17-8-9-22-18(21)12-17;1-14-4-2-6-16(12-14)22-20-24-23-19(26-20)15-5-3-7-18(13-15)25-17-8-10-21-11-9-17;1-11-4-2-6-13(8-11)22-19-25-17(26-27-19)12-5-3-7-14(9-12)28-16-10-15(20)23-18(21)24-16/h3-15H,1-2H3,(H2,27,28,29,30);2-15H,1H3,(H2,26,27,28,29);2-12H,1H3,(H,22,23,24)(H2,25,26,27,28);3-11H,1-2H3,(H,24,26)(H2,21,22,23);2-12H,1H3,(H,23,25)(H2,21,26,27);2-12H,1H3,(H2,21,22)(H,23,25);2-13H,1H3,(H,22,24);2-10H,1H3,(H4,20,21,23,24)(H2,22,25,26,27).

What are the key properties of 5-[3-(6-amino-2-methylpyrimidin-4-yl)oxyphenyl]-N-(3-methylphenyl)-1,3,4-oxadiazol-2-amine;5-[3-[(2-amino-4-pyridinyl)oxy]phenyl]-N-(3-methylphenyl)-1,3,4-oxadiazol-2-amine;5-[3-(7-methoxyquinolin-4-yl)oxyphenyl]-N-(3-methylphenyl)-1H-1,2,4-triazol-3-amine;4-[3-[5-(3-methylanilino)-1,3,4-oxadiazol-2-yl]phenoxy]pyridine-3-sulfonamide;6-[3-[3-(3-methylanilino)-1H-1,2,4-triazol-5-yl]phenoxy]pyrimidine-2,4-diamine;N-(3-methylphenyl)-5-(3-pyridin-4-yloxyphenyl)-1,3,4-oxadiazol-2-amine;N-(3-methylphenyl)-5-[3-(7H-pyrrolo[2,3-d]pyrimidin-4-yloxy)phenyl]-1H-1,2,4-triazol-3-amine;N-(3-methylphenyl)-5-(3-quinolin-4-yloxyphenyl)-1H-1,2,4-triazol-3-amine?

5-[3-(6-amino-2-methylpyrimidin-4-yl)oxyphenyl]-N-(3-methylphenyl)-1,3,4-oxadiazol-2-amine;5-[3-[(2-amino-4-pyridinyl)oxy]phenyl]-N-(3-methylphenyl)-1,3,4-oxadiazol-2-amine;5-[3-(7-methoxyquinolin-4-yl)oxyphenyl]-N-(3-methylphenyl)-1H-1,2,4-triazol-3-amine;4-[3-[5-(3-methylanilino)-1,3,4-oxadiazol-2-yl]phenoxy]pyridine-3-sulfonamide;6-[3-[3-(3-methylanilino)-1H-1,2,4-triazol-5-yl]phenoxy]pyrimidine-2,4-diamine;N-(3-methylphenyl)-5-(3-pyridin-4-yloxyphenyl)-1,3,4-oxadiazol-2-amine;N-(3-methylphenyl)-5-[3-(7H-pyrrolo[2,3-d]pyrimidin-4-yloxy)phenyl]-1H-1,2,4-triazol-3-amine;N-(3-methylphenyl)-5-(3-quinolin-4-yloxyphenyl)-1H-1,2,4-triazol-3-amine has a molecular weight of 3076.37 g/mol, XLogP of 37.01, 42 rotatable bonds, 18 hydrogen bond donors, and 54 hydrogen bond acceptors.

Where does this data come from?

All data for 5-[3-(6-amino-2-methylpyrimidin-4-yl)oxyphenyl]-N-(3-methylphenyl)-1,3,4-oxadiazol-2-amine;5-[3-[(2-amino-4-pyridinyl)oxy]phenyl]-N-(3-methylphenyl)-1,3,4-oxadiazol-2-amine;5-[3-(7-methoxyquinolin-4-yl)oxyphenyl]-N-(3-methylphenyl)-1H-1,2,4-triazol-3-amine;4-[3-[5-(3-methylanilino)-1,3,4-oxadiazol-2-yl]phenoxy]pyridine-3-sulfonamide;6-[3-[3-(3-methylanilino)-1H-1,2,4-triazol-5-yl]phenoxy]pyrimidine-2,4-diamine;N-(3-methylphenyl)-5-(3-pyridin-4-yloxyphenyl)-1,3,4-oxadiazol-2-amine;N-(3-methylphenyl)-5-[3-(7H-pyrrolo[2,3-d]pyrimidin-4-yloxy)phenyl]-1H-1,2,4-triazol-3-amine;N-(3-methylphenyl)-5-(3-quinolin-4-yloxyphenyl)-1H-1,2,4-triazol-3-amine is sourced from PubChem (CID 159560328), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).